Corporate & Securities Law Community | LexisNexis
Featured Content

06/21/2010 04:21:00 PM EST

Biovail, Valeant Pharma agree to combine

NEW YORK-(AP) Canadian drugmaker Biovail Corp. and Valeant Pharmaceuticals International said Monday they are forming a new company under the Valeant name, capping Biovail's recovery from falling sales and financial scandals.

Combined, the companies had $1.65 billion in revenue in 2009. They say their size, financial strength and product lines will allow…

Subscribers to www.lexis.com may read the full version of this article here.


Add a Comment

(required)  
(optional)
(required)  
Enter the Image Code: